These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
582 related items for PubMed ID: 22442730
1. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. Yang C, Jin C, Li X, Wang F, McKeehan WL, Luo Y. PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730 [Abstract] [Full Text] [Related]
2. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Wu X, Ge H, Lemon B, Weiszmann J, Gupte J, Hawkins N, Li X, Tang J, Lindberg R, Li Y. Proc Natl Acad Sci U S A; 2009 Aug 25; 106(34):14379-84. PubMed ID: 19706524 [Abstract] [Full Text] [Related]
12. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Adams AC, Yang C, Coskun T, Cheng CC, Gimeno RE, Luo Y, Kharitonenkov A. Mol Metab; 2012 Feb 25; 2(1):31-7. PubMed ID: 24024127 [Abstract] [Full Text] [Related]
13. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Aaldijk AS, Verzijl CRC, Jonker JW, Struik D. Front Endocrinol (Lausanne); 2023 Feb 25; 14():1150222. PubMed ID: 37260446 [Abstract] [Full Text] [Related]
14. Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma. Lin ZZ, Hsu C, Jeng YM, Hu FC, Pan HW, Wu YM, Hsu HC, Hu MC, Cheng AL. Liver Int; 2019 Sep 25; 39(9):1682-1691. PubMed ID: 30698907 [Abstract] [Full Text] [Related]
15. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, Hecht R, Gupte J, Hager T, Wang Z, Lindberg R, Li Y. J Biol Chem; 2010 Feb 19; 285(8):5165-70. PubMed ID: 20018895 [Abstract] [Full Text] [Related]
16. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma. Tao Z, Cui Y, Xu X, Han T. Proc Natl Acad Sci U S A; 2022 Oct 04; 119(40):e2208844119. PubMed ID: 36179047 [Abstract] [Full Text] [Related]
17. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. Adams AC, Coskun T, Rovira AR, Schneider MA, Raches DW, Micanovic R, Bina HA, Dunbar JD, Kharitonenkov A. PLoS One; 2012 Oct 04; 7(5):e38438. PubMed ID: 22675463 [Abstract] [Full Text] [Related]
18. FGF21 in obesity and cancer: New insights. Lu W, Li X, Luo Y. Cancer Lett; 2021 Feb 28; 499():5-13. PubMed ID: 33264641 [Abstract] [Full Text] [Related]
19. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds. Pérez-Martí A, Sandoval V, Marrero PF, Haro D, Relat J. Horm Mol Biol Clin Investig; 2016 Sep 01; 30(1):. PubMed ID: 27583468 [Abstract] [Full Text] [Related]
20. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Gallego-Escuredo JM, Gómez-Ambrosi J, Catalan V, Domingo P, Giralt M, Frühbeck G, Villarroya F. Int J Obes (Lond); 2015 Jan 01; 39(1):121-9. PubMed ID: 24813368 [Abstract] [Full Text] [Related] Page: [Next] [New Search]